Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Nathan M. Shumway"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 11, Iss 6, Pp JC01-JC03 (2017)
Introduction: Peripheral Blood Smear (PBS) interpretation is a useful skill for Haematology/Oncology Clinicians (HOC). Aim: To explore practice patterns of PBS utilization for all benign haematology diagnosis in a non-simulated environment and to
Externí odkaz:
https://doaj.org/article/7f25138aaaf84b0089ac0489ee0dce0e
Autor:
Sathibalan Ponniah, Tommy A. Brown, Diane F. Hale, Constantin N. Baxevanis, N. F. Pistamaltzian, John W. Myers, Kaitlin M. Peace, Eleftheria A. Anastasopoulou, Doreen O. Jackson, Jennifer K. Litton, James L. Murray, Michael Papamichail, Nathan M. Shumway, James T. Symanowski, George E. Peoples, Alexandros Ardavanis, Elizabeth A. Mittendorf, Sonia A. Perez, Timothy J. Vreeland, Julia M. Greene, G. Travis Clifton
Publikováno v:
Breast Cancer Research and Treatment
Purpose AE37 and GP2 are HER2 derived peptide vaccines. AE37 primarily elicits a CD4+ response while GP2 elicits a CD8+ response against the HER2 antigen. These peptides were tested in a large randomized trial to assess their ability to prevent recur
Autor:
Diane F. Hale, Sathibalan Ponniah, Nathan M. Shumway, Michael Papamichail, Sonia A. Perez, Jennifer K. Litton, George E. Peoples, Alexandros Ardavanis, James L. Murray, Elizabeth A. Mittendorf, Constantin N. Baxevanis
Publikováno v:
Oncotarget
// Elizabeth A. Mittendorf 1,* , Alexandros Ardavanis 2 , Jennifer K. Litton 3 , Nathan M. Shumway 4 , Diane F. Hale 5 , James L. Murray 3 , Sonia A. Perez 2 , Sathibalan Ponniah 6 , Constantin N. Baxevanis 2 , Michael Papamichail 2 and George E. Peo
Autor:
Eleftheria A. Anastasopoulou, Alexandros Ardavanis, N. F. Pistamaltzian, George E. Peoples, Constantin N. Baxevanis, Diane F. Hale, Nathan M. Shumway, James L. Murray, Michael Papamichail, Sonia A. Perez, James T. Symanowski, Jennifer K. Litton, Sathibalan Ponniah, E. von Hofe, Elizabeth A. Mittendorf
Publikováno v:
Annals of Oncology. 27:1241-1248
Background AE37 is the Ii-Key hybrid of the MHC class II peptide, AE36 (HER2 aa:776–790). Phase I studies showed AE37 administered with granulocyte macrophage colony-stimulating factor (GM-CSF) to be safe and highly immunogenic. A prospective, rand
Autor:
Timothy J. Vreeland, Julia M. Greene, Jennifer K. Litton, Michael Papamichail, Sonia A. Perez, Alexandros Ardavanis, Guy T. Clifton, Nathan M. Shumway, James L. Murray, Erika J Schneble, Diane F. Hale, George E. Peoples, EA Mittendorf, John S. Berry, Alfred F. Trappey
Publikováno v:
Cancer Research. 76:P2-11
Introduction: We are conducting a phase II clinical trial of the GP2+GM-CSF vaccine for the prevention of breast cancer recurrence in disease-free, node-positive or high-risk node negative patients (pts). GP2 is an HLA-A2+-restricted immunogenic pept
Autor:
Marko Popovic, Ronald Chow, Nathan M. Shumway, Rudolph M. Navari, Carlo DeAngelis, Henry Lam, Nicholas Chiu, Leonard Chiu, Edward Chow, Mark Pasetka, Sherlyn Vuong, Milica Milakovic
Publikováno v:
Supportive Care in Cancer. 24:2381-2392
Olanzapine is a potent antipsychotic medication that inhibits a wide variety of receptors. It has been used in trials for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV). This study systematically investigates the effica
Autor:
Maria Miller, Kate Lathrop, Elizabeth P. Hernandez, Anand B. Karnad, Jennifer Jill Dacus, Nathan M. Shumway
Publikováno v:
Journal of Graduate Medical Education. 7:101-104
Background The Next Accreditation System (NAS) increases the focus on educational outcomes and meaningful evaluation of learners. This requires that key clinical faculty develop new assessment formats such as entrustable professional activities (EPAs
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 11, Iss 6, Pp JC01-JC03 (2017)
Introduction: Peripheral Blood Smear (PBS) interpretation is a useful skill for Haematology/Oncology Clinicians (HOC). Aim: To explore practice patterns of PBS utilization for all benign haematology diagnosis in a non-simulated environment and to eva
Autor:
George E. Peoples, Alfred F. Trappey, BS John, Guy T. Clifton, Nathan M. Shumway, Erika J Schneble, Diane F. Hale, Sathibalan Ponniah, Michael Papamichail, Sonia A. Perez, EA Mittendorf, Timothy J. Vreeland
Publikováno v:
Cancer Research. 73:P2-14
Background: HER2 over-expression is associated with more aggressive malignant disease. The introduction of trastuzumab and other HER2-directed therapies, however, has led to improved prognosis for patients (pts) with HER2 over-expressing (OE) tumors.
Autor:
Timothy J. Vreeland, Erika J Schneble, George E. Peoples, Sathibalan Ponniah, Alfred F. Trappey, Alan K. Sears, EA Mittendorf, Guy T. Clifton, Nathan M. Shumway, John S. Berry, Diane F. Hale
Publikováno v:
Cancer Research. 73:P4-13
BACKGROUND: HER2 is a commonly expressed tumor-associated antigen in breast (BrCa) and ovarian cancer (OvCa) and, therefore, an attractive target for immunotherapy. We have investigated HER2-derived peptides as vaccines mixed with GM-CSF to include G